Skip to content

H2020FP7HORIZON

Uniwersytet Medyczny Im Piastow Slaskich We Wroclawiu

Country
PLPoland
Defence projects
0
Projects, all programmes
16
As coordinator
1
EU contribution (CORDIS)
EUR 3,640,412
Active
2008 to 2025

Projects

16 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
SP-EUSocial Prescribing to promote and improve access to health and care services for people in vulnerable situations in EuropeHORIZON2025ParticipantEUR 201,063
RAPHAELINTEGRATING A PALLIATIVE CARE APPROACH FOR PATIENTS WITH HEART FAILUREHORIZON2024ParticipantEUR 351,775
ExoDiagAIEmpowering Personalized Therapeutics: Advancing 3D-Nano DLD Arrays and Raman Micro-Biochips for Precision Isolation, Segmentation, and Molecular Profiling of Exosomal Trop2 Biomarkers in TNBCHORIZON2024Associated partnerEUR 0
IntReALL 2020International Study for Treatment of Childhood Relapsed ALL 2020HORIZON2023ParticipantEUR 275,000
ETUDEEncompassing Training in fUnctional Disorders across EuropeH20202021ParticipantEUR 139,015
HEARTBIT_4.0HeartBIT_4.0 - Application of innovative Medical Data Science technologies for heart diseases.H20202020CoordinatorEUR 275,963
ConcePTIONBuilding an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generationH20202019Third partyNot stated
RECOMBStem-cell based gene therapy for recombination deficient SCID (RECOMB)H20202018ParticipantEUR 62,500
REGIONS4PERMEDINTERREGIONAL COORDINATION FOR A FAST AND DEEP UPTAKE OF PERSONALISED HEALTHH20202018ParticipantEUR 42,500
BETA3_LVHA multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart diseaseH20202015ParticipantEUR 654,585
SECURESecondary prEvention of CardiovascUlaR disease in the Elderly trialH20202015ParticipantEUR 211,251
EPICSTENTAntibody-functionalised cardiovascular stents for improved biocompatibility and reduced restenosisFP72013ParticipantEUR 159,330
INTREALLInternational study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and researchFP72011ParticipantEUR 286,700
BIOSTAT-CHFA systems BIOlogy Study to TAilored Treatment in Chronic Heart FailureFP72010ParticipantEUR 490,000
SICA-HFStudies Investigating Co-morbidities Aggravating Heart FailureFP72009ParticipantEUR 232,611
BIOELECTRICSURFACEElectrically modified biomaterials surfaceFP72008ParticipantEUR 258,120

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.